Advanced analytics. Better treatment.
Mission
Setting the standard for oncology diagnostics by combining deep tissue knowledge, advanced analytics, and relentless focus on patient benefit.
Where precision pathology meets therapeutic strategy.
We partner with pharma and biotech teams to:
- Develop companion diagnostics
- Profile tumor bank for targets
- Unlock spatial analytics
Rapid companion diagnostic prototyping
Leverage our 500+ optimized immunohistochemistry assays, assay development expertise, and extensive archival tumor collection to validate spatial biomarkers quickly, giving pharma partners a clear, first-mover advantage.
Tissue-informed drug development insights
Integrate protein multiplexing with spatial analytics to create micro‑environment heat maps that uncover novel, druggable niches.
Regulatory grade assay transfer
With pathologist oversight and validated reagents, we move discovery assays to CLIA-compliant LDTs faster than large CROs, occupying the uncontested territory between academic labs and high-volume diagnostics firms.
AI-ready spatial data sets
Deliver curated H&E/IHC whole‑slide images paired with matched spatial annotations – rare, high-value inputs that supercharge machine‑learning pipelines.